Encouraging Solar Development through SREC Financing
Client Alert | 1 min read | 04.12.17
The promotion of renewable energy has been an important policy goal at the state and federal levels in recent years, and public support for solar energy in particular has driven a significant increase in installed solar capacity across the United States. There are numerous federal, state and local tax incentives which encourage consumers, businesses and utilities to increase renewable energy consumption, and solar developers offer attractive financing opportunities for consumers and businesses considering the installation of solar panels to reduce their electricity costs. More recently, solar developers themselves have begun to explore financing opportunities related to another solar incentive program, Solar Renewable Energy Certificates/Credits (“SRECs”), which can provide a valuable source of liquidity for developers and other owners of solar projects.
In this client alert, Jennifer K. Grady and Kevin Rubinstein discuss the use of SRECs as a source of financing and explore the key legal and business issues raised by such a financing structure.
Contacts
Insights
Client Alert | 8 min read | 06.30.25
AI Companies Prevail in Path-Breaking Decisions on Fair Use
Last week, artificial intelligence companies won two significant copyright infringement lawsuits brought by copyright holders, marking an important milestone in the development of the law around AI. These decisions – Bartz v. Anthropic and Kadrey v. Meta (decided on June 23 and 25, 2025, respectively), along with a February 2025 decision in Thomson Reuters v. ROSS Intelligence – suggest that AI companies have plausible defenses to the intellectual property claims that have dogged them since generative AI technologies became widely available several years ago. Whether AI companies can, in all cases, successfully assert that their use of copyrighted content is “fair” will depend on their circumstances and further development of the law by the courts and Congress.
Client Alert | 3 min read | 06.30.25
Client Alert | 3 min read | 06.26.25
FDA Targets Gene Editing Clinical Trials in China and other “Hostile Countries”
Client Alert | 3 min read | 06.26.25
